» Articles » PMID: 11330148

[Why Researchers Excluded Women from Their Trial Populations]

Overview
Journal Lakartidningen
Specialty General Medicine
Date 2001 May 2
PMID 11330148
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Women are still, but to a lesser extent than twenty years ago, excluded as subjects of medical research on diseases that are prevalent among both men and women. To discover the basis on which women were excluded, the research ethics committee requested a written explanation. In all, 26 such project applications were identified during 1997-1999 (2% of the total number of applications during the period). Most researchers had more than one reason for exclusion. Qualitative analysis revealed that these explanations could be grouped into three categories, depending on whether women were excluded for scientific, historical or economic reasons. The scientific reasons correspond mainly to a lack of pertinent knowledge of the physiology and metabolism of women of childbearing age. Consequently, results lacked external validity. Perhaps the lack of knowledge of women's physiology and metabolism could be explained by a lack of female experimental animals in pre-clinical studies. One notes however a general concern not to harm women of childbearing age. The historical reasons underlie the tendency to repeat studies on former study populations that happened to be composed of men. Finally, tight research budgets restricted the participation of women but not of men. The Swedish Medical Research Council issued a policy document in 1998 to the effect that research ethics committees could require additional information concerning choice of study population. This study demonstrates an avoidable occurrence of gender bias in medical research.

Citing Articles

Sex and gender in perioperative cardiovascular research: protocol for a scoping review.

Sjaus A, Fakhory N Syst Rev. 2025; 14(1):6.

PMID: 39780233 PMC: 11708003. DOI: 10.1186/s13643-024-02716-9.


The influence of sex-specific factors on biological transformations and health outcomes in aging processes.

Huang Y, Li H, Liang R, Chen J, Tang Q Biogerontology. 2024; 25(5):775-791.

PMID: 39001953 PMC: 11374838. DOI: 10.1007/s10522-024-10121-x.


Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis.

Rivera F, Tang V, De Luna D, Lerma E, Vijayaraghavan K, Kazory A Am Heart J Plus. 2023; 26.

PMID: 37305172 PMC: 10256233. DOI: 10.1016/j.ahjo.2023.100261.


Functional neurological disorder is a feminist issue.

McLoughlin C, Hoeritzauer I, Cabreira V, Aybek S, Adams C, Alty J J Neurol Neurosurg Psychiatry. 2023; 94(10):855-862.

PMID: 36977553 PMC: 10511956. DOI: 10.1136/jnnp-2022-330192.


From Learning to Relearning: A Framework for Diminishing Bias in Social Robot Navigation.

Hurtado J, Londono L, Valada A Front Robot AI. 2021; 8:650325.

PMID: 33842558 PMC: 8024571. DOI: 10.3389/frobt.2021.650325.